Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

004IC - Difficult Cases in High-Risk Bladder Cancer: An Evidenced-Based Approach

Friday, May 18
7:30 AM - 9:30 AM
Location: MCC WEST, 2004

The course director will select 6 real cases from his own practice that represent challenging cases in bladder cancer and present them to his panelists. The panelists will review the available literature and formulate a treatment plan based upon the guidelines and published literature. The course director will then present the actual patient outcome and readdress the panelists with follow-up problems and questions to illustrate the many unique aspects of dealing with these patients.

Learning Objectives:

Michael S. Cookson

University of Oklahoma

Michael S. Cookson, M.D. is Professor and Chairman of the Department of Urology at the University of Oklahoma Health Sciences Center and holds the Donald D. Albers Endowed Chair in Urology. An accomplished researcher and lecturer, he is the author of 250 peer-reviewed journal publications and chapters of various textbooks in urology and urologic surgery, and is recognized nationally for outstanding contributions to urologic oncology.
Dr. Cookson completed his Urology residency at the University of Texas, San Antonio and completed his Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. He was a member of the faculty at Vanderbilt University from 1998 to 2013, where he served as the Vice Chairman of Urologic Surgery and Director of the Urologic Oncology Fellowship Program.
Dr. Cookson has devoted a significant portion of his academic career to the management of patients with urologic cancers, with a strong emphasis on Clinical Guidelines, Education and Evidenced Based Medicine. He was a member of the AUA/ABU examination committee for 10 years, including Task for Cancer, Oncology Consultant and Pathology editor. He also serves on the ABU Oral Examination Committee. He is a co-founder of the OKAT, an SUO mandated oncology examination that is the standard for benchmarking for members and oncology fellows in training and served as Chair of that OKAT committee for 5 years. In 2011, he received the President’s Distinguished Service Award from the SUO for educational contributions. For his efforts in teaching at Vanderbilt, he was awarded the Michael Rodriquez Award.
Dr. Cookson recently served as the Chair of the AUA Guidelines Committee on Castration Resistant Prostate Cancer, and has previously served as the member of the AUA Guidelines on localized prostate cancer. He served as Treasurer for the SUO and is the SUO President Elect for 2018-2019.

Presentation(s):

Send Email for Michael Cookson

Jeffrey M. Holzbeierlein

University of Kansas Health System

Dr. Jeffrey Holzbeierlein is the John W. Weigel Endowed Professor of Urology, the Director of Urologic Oncology, and the Chair of the Department of Urology at the University of Kansas Medical Center. He was raised in Edmond, Oklahoma and received his undergraduate degree from Vanderbilt University and his medical degree from the University of Oklahoma. He joined the faculty at KU after completing his internship and residency at Vanderbilt University and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York.

Dr. Holzbeierlein is the immediate Past President of the South Central Section of the American Urological Association. He is the Secretary of the Society of Urologic Oncology where he is the past Chair of the Fellowship Committee and serves on the Executive Board of the SUO. He has served on the American Board of Urology Examination Committee and is a past Assistant Editor for the Journal of Urology. He currently is a member of the Oral Boards Committee and has served on numerous AUA Committees. He is the Chair for the Program Committee for GU ASCO. Dr. Holzbeierlein is also the past Chair and founding member of the Young Urologic Oncologists Section of the Society of Urologic Oncology. He has also been awarded the Resident Mentoring Award for faculty at the University of Kansas Hospital and the Distinguished Service Award from the Society of Urologic Oncology.

He has intramural and extramural grant support including a co-investigator on an R01, and as PI on several investigator initiated trials as well as a co-PI on a multi-instituntional SWOG trial.

Dr. Holzbeierlein's research interest includes the androgen receptor as a target of Hsp90 inhibitors in prostate cancer and clinically decreasing the morbidity associated with cystectomy. He lives in Kansas City with his wife Jill and their 4 children.

Presentation(s):

Send Email for Jeffrey Holzbeierlein

Timothy A. Masterson

Indiana University School of Medicine

Timothy A. Masterson, MD is an Associate Professor in the Department of Urology at the Indiana University School of Medicine in Indianapolis, Indiana. His clinical and research interests are in urologic oncology and complex adult urinary tract reconstruction. He also serves as the director for the Society of Urologic Oncology (SUO) Fellowship at Indiana University.

Presentation(s):

Send Email for Timothy Masterson


Assets

004IC - Difficult Cases in High-Risk Bladder Cancer: An Evidenced-Based Approach

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Difficult Cases in High-Risk Bladder Cancer: An Evidenced-Based Approach